logo-74

Global Embedded Computer Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Embedded Computer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...

logo-73

Global Embedded Computer Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Embedded Computer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...

logo-73

Asia-Pacific Mobile Advertising Markets, 2022-2026 with 2021 as the Base Year – Focus on In-App, Mobile Web, and Mobile Video Advertising – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Mobile Advertising Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The study evaluates the mobile advertising...

logo-72

India Off-highway Equipment (OHE) Market Analysis/Opportunities Report 2022-2030: Surge in the Mechanization of Processes, Demand for Rental and Leasing Models, Proliferation of Telematics – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indian Off-highway Equipment (OHE) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The growth of online models...

logo-71

2022 Myanmar Energy Monitor Premium Subscription: Featuring ABB Myanmar, AMOE Energy, APR Energy and Able Winners Among Others – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Myanmar Energy Monitor (Premium Subscription)" newsletter has been added to ResearchAndMarkets.com's offering. The Myanmar Energy Monitor enables companies...

logo-70

Global Land Survey Equipment Market Forecast to 2028 – Development of Terrestrial Laser Scanners Presents Opportunities – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Land Survey Equipment Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Solution, Industry, Application...

DaiichiSankyo-logo-4

Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials

Daiichi Sankyo and AstraZeneca’s TROP2 directed ADC showed an encouraging objective response rate of 32% and a manageable safety profile...

DaiichiSankyo-logo-3

Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials

Daiichi Sankyo and AstraZeneca’s TROP2 directed ADC showed an encouraging objective response rate of 32% and a manageable safety profile...